Hba1c levels and diabetes risk
Pro Research Analysisby 
Searched over 200M research papers
HbA1c Levels as a Predictor of Diabetes Risk
Hemoglobin A1c (HbA1c) is widely recognized as a key marker for long-term blood sugar control and is used to diagnose diabetes and assess the risk of developing the disease. Elevated HbA1c levels are strongly linked to a higher risk of developing type 2 diabetes in both adults and children, with risk increasing as HbA1c rises above normal thresholds. For example, children and adolescents with HbA1c levels of 5.7% or higher have a much greater risk of developing diabetes compared to those with lower levels, and this predictive value is similar to that of fasting plasma glucose and 2-hour postload glucose tests . In high-risk adults, such as those with metabolic syndrome or cardiovascular disease, higher HbA1c levels (especially 6.0–6.4%) are associated with a significantly increased risk of progressing to type 2 diabetes and developing complications like diabetic retinopathy .
HbA1c and the Progression and Worsening of Diabetes
Longitudinal studies show that HbA1c levels measured during routine health check-ups are correlated with the risk of developing diabetes and the likelihood of disease worsening. However, a single year’s HbA1c measurement may not be sufficient to fully predict future risk; repeated measurements over time provide a clearer picture . Consistently elevated HbA1c levels, or an increase over time, are strong indicators of future diabetes onset and the need for more intensive treatment.
HbA1c and Risk of Diabetes Complications
Higher HbA1c levels are not only linked to the development of diabetes but also to the risk of long-term complications, including cardiovascular disease, stroke, and diabetic retinopathy 368. Even in people without diagnosed diabetes, those with prediabetes-range HbA1c (6.0–6.4%) have a higher risk of cardiovascular events compared to those with lower levels, although much of this risk is due to other conventional cardiovascular risk factors .
HbA1c and Mortality Risk in People with Diabetes
The relationship between HbA1c and mortality in people with diabetes is complex and often non-linear. Several large studies have found a U-shaped or J-shaped association, where both very high and very low HbA1c levels are linked to increased risk of death 1479. For example, in patients with cardiovascular disease and diabetes, the lowest mortality risk was observed at an HbA1c of around 6.9%, with higher risks at both lower and higher levels . Similarly, in older adults and those with type 2 diabetes, mortality risk increases significantly when HbA1c exceeds 8.0% . In hemodialysis patients with diabetes, the risk of all-cause and cardiovascular mortality rises steadily as HbA1c increases above 7.5%, with cardiovascular deaths increasing more rapidly than other causes .
Individualized Glycemic Targets and HbA1c Variability
Recent research emphasizes the importance of individualized HbA1c targets, especially in people with type 2 diabetes and those at high cardiovascular risk. The optimal HbA1c target may vary depending on age, comorbidities, and the stability of blood sugar control. For patients with stable (low variability) HbA1c, lower targets are generally associated with lower risk. However, for those with high variability, aiming for a moderate HbA1c (around 7.8%) may minimize mortality risk, as aggressive lowering can sometimes increase risk .
Conclusion
HbA1c is a reliable and practical marker for assessing diabetes risk, monitoring disease progression, and predicting complications and mortality. Higher HbA1c levels are consistently associated with increased risk of developing diabetes, its complications, and death, but both excessively high and low levels can be harmful in people with established diabetes. Individualized glycemic targets, considering patient characteristics and HbA1c variability, are essential for optimizing outcomes and minimizing risks.
Sources and full results
Most relevant research papers on this topic